BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Bian S, Huang Y, Liang J, Fan Y, Zhang X. High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting: pH-Sensitive Pullulan-DOX Conjugate Nanoparticles for Hepatic Targeting. J Biomed Mater Res 2014;102:150-9. [DOI: 10.1002/jbm.a.34680] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Rahmani E, Pourmadadi M, Ghorbanian SA, Yazdian F, Rashedi H, Navaee M. Preparation of a pH‐responsive chitosan‐montmorillonite‐nitrogen‐doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy. Engineering in Life Sciences. [DOI: 10.1002/elsc.202200016] [Reference Citation Analysis]
2 Chis AA, Arseniu AM, Morgovan C, Dobrea CM, Frum A, Juncan AM, Butuca A, Ghibu S, Gligor FG, Rus LL. Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics 2022;14:1773. [DOI: 10.3390/pharmaceutics14091773] [Reference Citation Analysis]
3 Muthusamy S, Anandharaj SJ, Kumar PS, Meganathan Y, Vo DN, Vaidyanathan VK, Muthusamy S. Microbial pullulan for food, biomedicine, cosmetic, and water treatment: a review. Environ Chem Lett. [DOI: 10.1007/s10311-022-01460-7] [Reference Citation Analysis]
4 Fundueanu G, Constantin M, Turtoi M, Bucatariu SM, Cosman B, Anghelache M, Voicu G, Calin M. Bio-Responsive Carriers for Controlled Delivery of Doxorubicin to Cancer Cells. Pharmaceutics 2022;14:865. [PMID: 35456699 DOI: 10.3390/pharmaceutics14040865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ganie SA, Rather LJ, Li Q. A review on anticancer applications of pullulan and pullulan derivative nanoparticles. Carbohydrate Polymer Technologies and Applications 2021;2:100115. [DOI: 10.1016/j.carpta.2021.100115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jin Y, Wang Y, Liu X, Zhou J, Wang X, Feng H, Liu H. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Drug Des Devel Ther 2020;14:5205-15. [PMID: 33268983 DOI: 10.2147/DDDT.S260253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
7 Singh RS, Kaur N, Hassan M, Kennedy JF. Pullulan in biomedical research and development - A review. Int J Biol Macromol 2021;166:694-706. [PMID: 33137388 DOI: 10.1016/j.ijbiomac.2020.10.227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zheng Z, Pan X, Xu J, Wu Z, Zhang Y, Wang K. Advances in tracking of polysaccharides in vivo: Labeling strategies, potential factors and applications based on pharmacokinetic characteristics. International Journal of Biological Macromolecules 2020;163:1403-20. [DOI: 10.1016/j.ijbiomac.2020.07.210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tabernero A, Cardea S. Microbial Exopolysaccharides as Drug Carriers. Polymers (Basel) 2020;12:E2142. [PMID: 32961830 DOI: 10.3390/polym12092142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Luft L, Confortin TC, Todero I, Zabot GL, Mazutti MA. An overview of fungal biopolymers: bioemulsifiers and biosurfactants compounds production. Critical Reviews in Biotechnology 2020;40:1059-80. [DOI: 10.1080/07388551.2020.1805405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang B, Zhang W, Zhou X, Liu M, Hou X, Cheng Z, Chen D. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer. Drug Deliv 2019;26:1265-79. [PMID: 31777307 DOI: 10.1080/10717544.2019.1693707] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
12 Zhang W, Huang Z, Pu X, Chen X, Yin G, Wang L, Zhang F, Gao F. Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd2O3 nanorods with dual-model imaging and targeted therapy of brain tumor. Chinese Chemical Letters 2020;31:285-91. [DOI: 10.1016/j.cclet.2019.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
13 Gao P, Liu S, Su Y, Zheng M, Xie Z. Fluorine-Doped Carbon Dots with Intrinsic Nucleus-Targeting Ability for Drug and Dye Delivery. Bioconjugate Chem 2020;31:646-55. [DOI: 10.1021/acs.bioconjchem.9b00801] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yuan H, Li X, Tang J, Zhou M, Liu F. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats. Cancer Imaging 2019;19:71. [PMID: 31685015 DOI: 10.1186/s40644-019-0257-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
15 Yuan L, Guo B, Zhong W, Nie Y, Yao X, Peng X, Wang R, Yu H, Yang S, He C, Tao X, Zhang Q. Interaction of Mitoxantrone-Loaded Cholesterol Modified Pullulan Nanoparticles with Human Serum Albumin and Effect on Drug Release. Journal of Nanomaterials 2019;2019:1-13. [DOI: 10.1155/2019/8036863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Li H, Ma M, Zhang J, Hou W, Chen H, Zeng D, Wang Z. Ultrasound-Enhanced Delivery of Doxorubicin-Loaded Nanodiamonds from Pullulan-all-trans-Retinal Nanoparticles for Effective Cancer Therapy. ACS Appl Mater Interfaces 2019;11:20341-9. [DOI: 10.1021/acsami.9b03559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
17 Li H, Yu C, Zhang J, Li Q, Qiao H, Wang Z, Zeng D. pH-sensitive pullulan-doxorubicin nanoparticles loaded with 1,1,2-trichlorotrifluoroethane as a novel synergist for high intensity focused ultrasound mediated tumor ablation. International Journal of Pharmaceutics 2019;556:226-35. [DOI: 10.1016/j.ijpharm.2018.12.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
18 Pourjavadi A, Kohestanian M, Shirzad M. Synthesis and characterization of magnetic hybrid nanomaterials via RAFT polymerization: A pH sensitive drug delivery system. Colloids and Surfaces B: Biointerfaces 2019;174:153-60. [DOI: 10.1016/j.colsurfb.2018.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
19 Zhang X, Li D, Huang J, Ou K, Yan B, Shi F, Zhang J, Zhang J, Pang J, Kang Y, Wu J. Screening of pH-responsive long-circulating polysaccharide–drug conjugate nanocarriers for antitumor applications. J Mater Chem B 2019;7:251-64. [DOI: 10.1039/c8tb02474j] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
20 Pourjavadi A, Kohestanian M, Yaghoubi M. Poly(glycidyl methacrylate)-coated magnetic graphene oxide as a highly efficient nanocarrier: preparation, characterization, and targeted DOX delivery. New J Chem 2019;43:18647-56. [DOI: 10.1039/c9nj04623b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
21 Chen K, Zhang S, Wang H, Wang X, Zhang Y, Yu L, Ke L, Gong R. Fabrication of Doxorubicin-Loaded Glycyrrhetinic Acid-Biotin-Starch Nanoparticles and Drug Delivery Into HepG2 Cells In Vitro. Starch - Stärke 2019;71:1800031. [DOI: 10.1002/star.201800031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Seidi F, Jenjob R, Phakkeeree T, Crespy D. Saccharides, oligosaccharides, and polysaccharides nanoparticles for biomedical applications. Journal of Controlled Release 2018;284:188-212. [DOI: 10.1016/j.jconrel.2018.06.026] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 14.8] [Reference Citation Analysis]
23 Seidi F, Jenjob R, Crespy D. Designing Smart Polymer Conjugates for Controlled Release of Payloads. Chem Rev 2018;118:3965-4036. [PMID: 29533067 DOI: 10.1021/acs.chemrev.8b00006] [Cited by in Crossref: 129] [Cited by in F6Publishing: 156] [Article Influence: 32.3] [Reference Citation Analysis]
24 Yang X, Shi X, D'arcy R, Tirelli N, Zhai G. Amphiphilic polysaccharides as building blocks for self-assembled nanosystems: molecular design and application in cancer and inflammatory diseases. Journal of Controlled Release 2018;272:114-44. [DOI: 10.1016/j.jconrel.2017.12.033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
25 Ivanenkov YA, Majouga AG, Petrov RA, Petrov SA, Kovalev SV, Maklakova SY, Yamansarov EY, Saltykova IV, Deyneka EV, Filkov GI, Kotelianski VE, Zatsepin TS, Beloglazkina EK. Synthesis and biological evaluation of novel doxorubicin-containing ASGP-R-targeted drug-conjugates. Bioorganic & Medicinal Chemistry Letters 2018;28:503-8. [DOI: 10.1016/j.bmcl.2017.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
26 Xu L, Cui G, Ke C, Fan Y, Yan Y. Immobilized Burkholderia cepacia Lipase on pH-Responsive Pullulan Derivatives with Improved Enantioselectivity in Chiral Resolution. Catalysts 2018;8:13. [DOI: 10.3390/catal8010013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
27 K.r. S, V. P. Review on production, downstream processing and characterization of microbial pullulan. Carbohydrate Polymers 2017;173:573-91. [DOI: 10.1016/j.carbpol.2017.06.022] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
28 Singh RS, Kaur N, Rana V, Kennedy JF. Pullulan: A novel molecule for biomedical applications. Carbohydrate Polymers 2017;171:102-21. [DOI: 10.1016/j.carbpol.2017.04.089] [Cited by in Crossref: 128] [Cited by in F6Publishing: 127] [Article Influence: 25.6] [Reference Citation Analysis]
29 Zeng H, Li X, Sun M, Wu S, Chen H. Synthesis of Europium-Doped Fluorapatite Nanorods and Their Biomedical Applications in Drug Delivery. Molecules 2017;22:E753. [PMID: 28481233 DOI: 10.3390/molecules22050753] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
30 Sui J, Cui Y, Cai H, Bian S, Xu Z, Zhou L, Sun Y, Liang J, Fan Y, Zhang X. Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma. Nanoscale 2017;9:2755-67. [DOI: 10.1039/c6nr09639e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
31 Dosekova E, Filip J, Bertok T, Both P, Kasak P, Tkac J. Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes. Med Res Rev 2017;37:514-626. [PMID: 27859448 DOI: 10.1002/med.21420] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
32 Hu H, Li Y, Zhou Q, Ao Y, Yu C, Wan Y, Xu H, Li Z, Yang X. Redox-Sensitive Hydroxyethyl Starch–Doxorubicin Conjugate for Tumor Targeted Drug Delivery. ACS Appl Mater Interfaces 2016;8:30833-44. [DOI: 10.1021/acsami.6b11932] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 10.0] [Reference Citation Analysis]
33 Lin C, Kuan C, Wang L, Wu H, Chen Y, Chang C, Huang R, Wang T. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics. Biomaterials 2016;90:12-26. [DOI: 10.1016/j.biomaterials.2016.03.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
34 Dheer D, Arora D, Jaglan S, Rawal RK, Shankar R. Polysaccharides based nanomaterials for targeted anti-cancer drug delivery. Journal of Drug Targeting 2016;25:1-16. [DOI: 10.3109/1061186x.2016.1172589] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
35 Wong KE, Mora MC, Skinner M, Mcrae Page S, Crisi GM, Arenas RB, Schneider SS, Emrick T. Evaluation of PolyMPC–Dox Prodrugs in a Human Ovarian Tumor Model. Mol Pharmaceutics 2016;13:1679-87. [DOI: 10.1021/acs.molpharmaceut.6b00092] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
36 Wang S, Deng H, Huang P, Sun P, Huang X, Su Y, Zhu X, Shen J, Yan D. Real-time self-tracking of an anticancer small molecule nanodrug based on colorful fluorescence variations. RSC Adv 2016;6:12472-8. [DOI: 10.1039/c5ra24273h] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
37 Liu K, Jiang X, Hunziker P. Carbohydrate-based amphiphilic nano delivery systems for cancer therapy. Nanoscale 2016;8:16091-156. [DOI: 10.1039/c6nr04489a] [Cited by in Crossref: 93] [Cited by in F6Publishing: 101] [Article Influence: 15.5] [Reference Citation Analysis]
38 Pang X, Jiang Y, Xiao Q, Leung AW, Hua H, Xu C. pH-responsive polymer–drug conjugates: Design and progress. Journal of Controlled Release 2016;222:116-29. [DOI: 10.1016/j.jconrel.2015.12.024] [Cited by in Crossref: 158] [Cited by in F6Publishing: 177] [Article Influence: 26.3] [Reference Citation Analysis]
39 Alhaique F, Matricardi P, Di Meo C, Coviello T, Montanari E. Polysaccharide-based self-assembling nanohydrogels: An overview on 25-years research on pullulan. Journal of Drug Delivery Science and Technology 2015;30:300-9. [DOI: 10.1016/j.jddst.2015.06.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 4.9] [Reference Citation Analysis]
40 Krull SM, Ma Z, Li M, Davé RN, Bilgili E. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement. Drug Dev Ind Pharm 2016;42:1073-85. [PMID: 26567632 DOI: 10.3109/03639045.2015.1107094] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
41 Song H, Zhang J, Wang W, Huang P, Zhang Y, Liu J, Li C, Kong D. Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery. Colloids Surf B Biointerfaces 2015;136:365-74. [PMID: 26433349 DOI: 10.1016/j.colsurfb.2015.09.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
42 Li H, Cui Y, Sui J, Bian S, Sun Y, Liang J, Fan Y, Zhang X. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates. ACS Appl Mater Interfaces 2015;7:15855-65. [PMID: 26140410 DOI: 10.1021/acsami.5b03150] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
43 Xu W, Ding J, Xiao C, Li L, Zhuang X, Chen X. Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic. Biomaterials 2015;54:72-86. [DOI: 10.1016/j.biomaterials.2015.03.021] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 14.1] [Reference Citation Analysis]
44 Singh RS, Kaur N, Kennedy JF. Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting. Carbohydrate Polymers 2015;123:190-207. [DOI: 10.1016/j.carbpol.2015.01.032] [Cited by in Crossref: 137] [Cited by in F6Publishing: 131] [Article Influence: 19.6] [Reference Citation Analysis]
45 D'souza AA, Devarajan PV. Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications. Journal of Controlled Release 2015;203:126-39. [DOI: 10.1016/j.jconrel.2015.02.022] [Cited by in Crossref: 210] [Cited by in F6Publishing: 243] [Article Influence: 30.0] [Reference Citation Analysis]
46 Li H, Sun Y, Liang J, Fan Y, Zhang X. pH-Sensitive pullulan–DOX conjugate nanoparticles for co-loading PDTC to suppress growth and chemoresistance of hepatocellular carcinoma. J Mater Chem B 2015;3:8070-8. [DOI: 10.1039/c5tb01210d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
47 Zhang Y, Wang H, Mukerabigwi JF, Liu M, Luo S, Lei S, Cao Y, Huang X, He H. Self-organized nanoparticle drug delivery systems from a folate-targeted dextran–doxorubicin conjugate loaded with doxorubicin against multidrug resistance. RSC Adv 2015;5:71164-73. [DOI: 10.1039/c5ra10341j] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
48 Li J, Zhou Y, Li C, Wang D, Gao Y, Zhang C, Zhao L, Li Y, Liu Y, Li X. Poly(2-ethyl-2-oxazoline)–Doxorubicin Conjugate-Based Dual Endosomal pH-Sensitive Micelles with Enhanced Antitumor Efficacy. Bioconjugate Chem 2015;26:110-9. [DOI: 10.1021/bc5004718] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
49 Vora L, Tyagi M, Patel K, Gupta S, Vavia P. Self-assembled nanocomplexes of anionic pullulan and polyallylamine for DNA and pH-sensitive intracellular drug delivery. J Nanopart Res 2014;16. [DOI: 10.1007/s11051-014-2781-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
50 Luo C, Sun J, Sun B, He Z. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol Sci 2014;35:556-66. [PMID: 25441774 DOI: 10.1016/j.tips.2014.09.008] [Cited by in Crossref: 175] [Cited by in F6Publishing: 200] [Article Influence: 21.9] [Reference Citation Analysis]
51 Wang X, Wang J, Bao Y, Wang B, Wang X, Chen L. Novel reduction-sensitive pullulan-based micelles with good hemocompatibility for efficient intracellular doxorubicin delivery. RSC Adv 2014;4:60064-74. [DOI: 10.1039/c4ra12276c] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
52 Li H, Cui Y, Liu J, Bian S, Liang J, Fan Y, Zhang X. Reduction breakable cholesteryl pullulan nanoparticles for targeted hepatocellular carcinoma chemotherapy. J Mater Chem B 2014;2:3500-10. [DOI: 10.1039/c4tb00321g] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]